Eye Screening in German Secondary Diabetes Care Centers
NCT ID: NCT02311504
Last Updated: 2016-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
831 participants
OBSERVATIONAL
2014-01-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Main focus of the study is the concordance to the national screening recommendations (last eye exam, presence of retinopathy).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Stage Retinal Abnormalities in Type 1 Diabetes, Screened With OCT Angiography.
NCT03496597
AI Screening for Diabetic Retinopathy
NCT05704491
Measurement of Total Retinal Blood Flow and Oxygen Extraction in Patients With Diabetes and Healthy Subjects
NCT03552562
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control
NCT01323348
Measurement of Total Retinal Blood Flow in Patients With Diabetes and Healthy Subjects
NCT01843114
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DiabCheck ophta OCTplus
persons with diabetes undergoing OCT examination
OCT examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OCT examination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* in the case of blindness absence of a caregiver
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Eye Hospital
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Marahrens L, Ziemssen F, Fritsche A, Ziemssen T, Kern R, Martus P, Roeck D. Limited Time from the Diabetes Patients' Perspective: Need for Conversation with the Eye Specialist. Ophthalmologica. 2016;236(3):154-158. doi: 10.1159/000450708. Epub 2016 Oct 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DCophtaOCTplus14_C
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.